Taiwan
· Delayed Price · Currency is TWD Senhwa Biosciences Statistics
Total Valuation
TPEX:6492 has a market cap or net worth of TWD 2.98 billion. The enterprise value is 2.03 billion.
| Market Cap | 2.98B |
| Enterprise Value | 2.03B |
Important Dates
The last earnings date was Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6492 has 89.15 million shares outstanding.
| Current Share Class | 89.15M |
| Shares Outstanding | 89.15M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.28% |
| Owned by Insiders (%) | 2.04% |
| Owned by Institutions (%) | 0.17% |
| Float | 68.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,981.92 |
| PB Ratio | 3.09 |
| P/TBV Ratio | 3.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.97 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 43.57, with a Debt / Equity ratio of 0.01.
| Current Ratio | 43.57 |
| Quick Ratio | 43.22 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -487.03 |
Financial Efficiency
Return on equity (ROE) is -26.27% and return on invested capital (ROIC) is -16.87%.
| Return on Equity (ROE) | -26.27% |
| Return on Assets (ROA) | -16.63% |
| Return on Invested Capital (ROIC) | -16.87% |
| Return on Capital Employed (ROCE) | -31.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.61% in the last 52 weeks. The beta is 0.80, so TPEX:6492's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -18.61% |
| 50-Day Moving Average | 37.03 |
| 200-Day Moving Average | 45.12 |
| Relative Strength Index (RSI) | 46.85 |
| Average Volume (20 Days) | 81,382 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6492 had revenue of TWD 1.00 million and -291.97 million in losses. Loss per share was -3.27.
| Revenue | 1.00M |
| Gross Profit | 470,000 |
| Operating Income | -304.39M |
| Pretax Income | -290.69M |
| Net Income | -291.97M |
| EBITDA | -302.09M |
| EBIT | -304.39M |
| Loss Per Share | -3.27 |
Balance Sheet
The company has 959.50 million in cash and 11.94 million in debt, giving a net cash position of 947.56 million or 10.63 per share.
| Cash & Cash Equivalents | 959.50M |
| Total Debt | 11.94M |
| Net Cash | 947.56M |
| Net Cash Per Share | 10.63 |
| Equity (Book Value) | 966.44M |
| Book Value Per Share | 10.87 |
| Working Capital | 945.39M |
Cash Flow
| Operating Cash Flow | -279.82M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 47.00% |
| Operating Margin | -30,439.40% |
| Pretax Margin | -29,068.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6492 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.79% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |